Muscle imaging in dominant core myopathies linked or unlinked to the ryanodine receptor 1 gene

Neurology. 2006 Dec 26;67(12):2217-20. doi: 10.1212/01.wnl.0000249151.45200.71.

Abstract

Objective: To characterize the muscle involvement of patients with central core disease (CCD) caused by mutations in the ryanodine receptor 1 gene (RYR1) and to compare these findings with those from patients with core myopathies unlinked to the RYR1 gene.

Methods: We performed a systematic muscular imaging assessment in 11 patients with an RYR1 gene mutation and compared these findings with those of 5 patients from two unrelated families with autosomal dominant core myopathies not linked to RYR1, ACTA1, or MYH7 gene loci.

Results: All patients with RYR1 CCD had a characteristic pattern with predominant involvement of the gluteus maximus, adductor magnus, sartorius, vastus intermediolateralis, soleus, and lateral gastrocnemius muscles. In contrast, muscle CT in the first family not linked to RYR1 showed predominant affection of the gluteus minimus and hamstring muscles, whereas the second family presented with predominant involvement of the gluteus minimus, vastus intermediolateralis, tibialis anterior, and medial gastrocnemius muscles. In addition to muscle imaging data, we present detailed information on the clinical and pathologic findings of these novel phenotypes of core myopathies not linked to RYR1.

Conclusions: Our data suggest genetic heterogeneity in autosomal dominant core myopathies and the existence of additional unidentified genes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chromosome Disorders / genetics*
  • Chromosome Disorders / pathology*
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Muscle, Skeletal / pathology*
  • Myopathy, Central Core / genetics*
  • Myopathy, Central Core / pathology*
  • Ryanodine Receptor Calcium Release Channel / genetics*
  • Statistics as Topic

Substances

  • Ryanodine Receptor Calcium Release Channel